Coronavirus News

Medicine & Health News

Milner Foundation donates $3 million to Magen David Adom, TAU and Tel Aviv Sourasky Medical Center (Ichilov)

The Milner Foundation, founded by renowned tech investor and science philanthropist Yuri Milner and his wife Julia, has donated $3 million to three Israeli institutions currently leading a “race against the clock” to beat the coronavirus pandemic: Magen David Adom, Israel’s national emergency medical response organization, which is launching an innovative project to reduce the… Read More

Israeli universities, hospitals establish joint student volunteer initiative to increase and improve coronavirus testing across Israel

Israeli hospitals and universities, including Tel Aviv University, have joined forces to build an enormous student volunteer base to expand and improve the detection of people infected with novel coronavirus all over Israel. In addition, TAU, together with the Weizmann Institute of Science and other institutes in Israel, has recruited over 600 doctoral students to… Read More

New sleep method strengthens brain’s ability to retain memories

A new joint study by Tel Aviv University (TAU) and Weizmann Institute of Science researchers has yielded an innovative method for bolstering memory processes in the brain during sleep. The method relies on a memory-evoking scent administered to one nostril. It helps researchers understand how sleep aids memory, and in the future could possibly help to restore memory… Read More

High blood pressure in young adulthood associated with cognitive decline and gait impairment in middle age

High blood pressure, or hypertension, affects everything from your arteries to your kidneys, from eyesight to sexual function. Among older adults, high blood pressure is also associated with cognitive decline as a result of interrupted blood flow to the brain, as well as strokes, heart attacks and impaired mobility. A new Northwestern University–Tel Aviv University study… Read More

TAU researchers discover receptor chain involved in atopic dermatitis

Atopic dermatitis, a chronic inflammatory disorder, affects some 30 million Americans every year. It is the most common cause of eczema, a condition marked by unbearably itchy, flaky patches of skin. A new Tel Aviv University study identifies the precise receptor chain involved in the development of atopic dermatitis. The researchers hope to develop an antibody based… Read More

Enhancing drug testing with human body-on-chip systems

The U.S. Food and Drug Administration (FDA) approves only 13.8% of all tested drugs, and these numbers are even lower in “orphan” diseases that affect relatively few people. Part of the problem lies in the imperfect nature of preclinical drug testing that aims to exclude toxic effects and predetermine concentrations and administration routes before drug… Read More

Fibroblasts involved in healing spur tumor growth in cancer

The connective tissue cells known as fibroblasts are vitally important for our recovery from injury. Sensing tissue damage, they gravitate to the site of a wound, instigating an inflammatory response that mends damaged tissue. A new Tel Aviv University study published in Nature Communications on September 26 finds that fibroblasts also play a devastating role… Read More